These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 24101030)
1. The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations. Barbosa DJ; Capela JP; Silva R; Vilas-Boas V; Ferreira LM; Branco PS; Fernandes E; Bastos Mde L; Carvalho F Arch Toxicol; 2014 Feb; 88(2):455-73. PubMed ID: 24101030 [TBL] [Abstract][Full Text] [Related]
2. "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites. Barbosa DJ; Capela JP; Silva R; Ferreira LM; Branco PS; Fernandes E; Bastos ML; Carvalho F Arch Toxicol; 2014 Feb; 88(2):515-31. PubMed ID: 24177245 [TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells. Ferreira PS; Nogueira TB; Costa VM; Branco PS; Ferreira LM; Fernandes E; Bastos ML; Meisel A; Carvalho F; Capela JP Toxicol Lett; 2013 Feb; 216(2-3):159-70. PubMed ID: 23194825 [TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity of Ecstasy metabolites in rat cortical neurons, and influence of hyperthermia. Capela JP; Meisel A; Abreu AR; Branco PS; Ferreira LM; Lobo AM; Remião F; Bastos ML; Carvalho F J Pharmacol Exp Ther; 2006 Jan; 316(1):53-61. PubMed ID: 16183702 [TBL] [Abstract][Full Text] [Related]
6. The mixture of "ecstasy" and its metabolites impairs mitochondrial fusion/fission equilibrium and trafficking in hippocampal neurons, at in vivo relevant concentrations. Barbosa DJ; Serrat R; Mirra S; Quevedo M; de Barreda EG; Àvila J; Ferreira LM; Branco PS; Fernandes E; Lourdes Bastos Md; Capela JP; Soriano E; Carvalho F Toxicol Sci; 2014 Jun; 139(2):407-20. PubMed ID: 24595818 [TBL] [Abstract][Full Text] [Related]
7. Mixtures of 3,4-methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non-cytotoxic concentrations. da Silva DD; Silva E; Carvalho F; Carmo H J Appl Toxicol; 2014 Jun; 34(6):618-27. PubMed ID: 23670916 [TBL] [Abstract][Full Text] [Related]
8. The toxicity of N-methyl-alpha-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine. Carvalho M; Remião F; Milhazes N; Borges F; Fernandes E; Carvalho F; Bastos ML Toxicology; 2004 Aug; 200(2-3):193-203. PubMed ID: 15212815 [TBL] [Abstract][Full Text] [Related]
9. Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro. Carvalho M; Remião F; Milhazes N; Borges F; Fernandes E; Monteiro Mdo C; Gonçalves MJ; Seabra V; Amado F; Carvalho F; Bastos ML Chem Res Toxicol; 2004 May; 17(5):623-32. PubMed ID: 15144219 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): comparison with related catecholamines. Felim A; Herrera G; Neudörffer A; Blanco M; O'Connor JE; Largeron M Chem Res Toxicol; 2010 Jan; 23(1):211-9. PubMed ID: 20017534 [TBL] [Abstract][Full Text] [Related]
12. Metabolites of MDMA induce oxidative stress and contractile dysfunction in adult rat left ventricular myocytes. Shenouda SK; Varner KJ; Carvalho F; Lucchesi PA Cardiovasc Toxicol; 2009 Mar; 9(1):30-8. PubMed ID: 19333788 [TBL] [Abstract][Full Text] [Related]
13. Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Carvalho M; Hawksworth G; Milhazes N; Borges F; Monks TJ; Fernandes E; Carvalho F; Bastos ML Arch Toxicol; 2002 Oct; 76(10):581-8. PubMed ID: 12373454 [TBL] [Abstract][Full Text] [Related]
14. Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity. Escubedo E; Abad S; Torres I; Camarasa J; Pubill D Neurochem Int; 2011 Jan; 58(1):92-101. PubMed ID: 21074589 [TBL] [Abstract][Full Text] [Related]
15. Serotonergic neurotoxic metabolites of ecstasy identified in rat brain. Jones DC; Duvauchelle C; Ikegami A; Olsen CM; Lau SS; de la Torre R; Monks TJ J Pharmacol Exp Ther; 2005 Apr; 313(1):422-31. PubMed ID: 15634943 [TBL] [Abstract][Full Text] [Related]
16. The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Monks TJ; Jones DC; Bai F; Lau SS Ther Drug Monit; 2004 Apr; 26(2):132-6. PubMed ID: 15228153 [TBL] [Abstract][Full Text] [Related]
17. Modeling chronic brain exposure to amphetamines using primary rat neuronal cortical cultures. Nogueira TB; da Costa Araújo S; Carvalho F; Pereira FC; Fernandes E; Bastos ML; Costa VM; Capela JP Neuroscience; 2014 Sep; 277():417-34. PubMed ID: 25047998 [TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Carvalho M; Milhazes N; Remião F; Borges F; Fernandes E; Amado F; Monks TJ; Carvalho F; Bastos ML Arch Toxicol; 2004 Jan; 78(1):16-24. PubMed ID: 14586543 [TBL] [Abstract][Full Text] [Related]
19. Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells. Feio-Azevedo R; Costa VM; Ferreira LM; Branco PS; Pereira FC; Bastos ML; Carvalho F; Capela JP Toxicol Lett; 2017 Mar; 269():65-76. PubMed ID: 28115274 [TBL] [Abstract][Full Text] [Related]
20. Glial cell response to 3,4-(+/-)-methylenedioxymethamphetamine and its metabolites. Herndon JM; Cholanians AB; Lau SS; Monks TJ Toxicol Sci; 2014 Mar; 138(1):130-8. PubMed ID: 24299738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]